NO934381L - Terapeutiske sammensetninger for osteoinduksjon - Google Patents

Terapeutiske sammensetninger for osteoinduksjon

Info

Publication number
NO934381L
NO934381L NO934381A NO934381A NO934381L NO 934381 L NO934381 L NO 934381L NO 934381 A NO934381 A NO 934381A NO 934381 A NO934381 A NO 934381A NO 934381 L NO934381 L NO 934381L
Authority
NO
Norway
Prior art keywords
osteoinduction
therapeutic compositions
mammal
safe
effective amount
Prior art date
Application number
NO934381A
Other languages
English (en)
Other versions
NO934381D0 (no
Inventor
Roger Lee Stone
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO934381D0 publication Critical patent/NO934381D0/no
Publication of NO934381L publication Critical patent/NO934381L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

En fremgangsmåte for å generere ny benvekst i et pattedyr omfattende å administrere til pattedyret en sikker og effektiv mengde av en vitamin D-for-bindelse i kombinasjon med en sikker og effektiv mengde av et osteoinduktivt ekstrakt eller minst ett benmorfogent protein.
NO934381A 1991-06-05 1993-12-02 Terapeutiske sammensetninger for osteoinduksjon NO934381L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US70962191A 1991-06-05 1991-06-05
US85611092A 1992-03-27 1992-03-27
PCT/US1992/004356 WO1992021365A1 (en) 1991-06-05 1992-05-26 Therapeutic compositions for osteoinduction

Publications (2)

Publication Number Publication Date
NO934381D0 NO934381D0 (no) 1993-12-02
NO934381L true NO934381L (no) 1994-01-31

Family

ID=27108286

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934381A NO934381L (no) 1991-06-05 1993-12-02 Terapeutiske sammensetninger for osteoinduksjon

Country Status (13)

Country Link
EP (1) EP0587751A1 (no)
JP (1) JPH06508140A (no)
AU (1) AU667815B2 (no)
BR (1) BR9206110A (no)
CA (1) CA2110410C (no)
CZ (1) CZ282231B6 (no)
IE (1) IE921812A1 (no)
NO (1) NO934381L (no)
NZ (1) NZ243018A (no)
PT (1) PT100567A (no)
RU (1) RU2107512C1 (no)
SK (1) SK136693A3 (no)
WO (1) WO1992021365A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
ATE308336T1 (de) * 1991-08-30 2005-11-15 Curis Inc Osteogenische proteine in der behandlung von metabolischen knochenkrankheiten
US6071695A (en) * 1992-02-21 2000-06-06 Creative Biomolecules, Inc. Methods and products for identification of modulators of osteogenic protein-1 gene expression
CN1104257C (zh) * 1993-03-29 2003-04-02 津莫吉尼蒂克斯公司 含pdgf和维生素d的刺激成骨细胞生长的组合物
AU703445B2 (en) * 1994-06-07 1999-03-25 Stryker Corporation Methods and compositions for modulating morphogenic protein expression
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US7026292B1 (en) 1995-12-12 2006-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6492508B1 (en) 1996-06-03 2002-12-10 United States Surgical Corp. A Division Of Tyco Healthcare Group Nucleic acids encoding extracellular matrix proteins
EP1350525A3 (en) * 1997-02-07 2003-12-10 Stryker Corporation Matrix-free osteogenic devices, implants and methods thereof
PL214839B1 (pl) * 2001-10-31 2013-09-30 Alcon Zastosowanie antagonisty gremliny do wytwarzania leku
CN101668532B (zh) * 2007-04-25 2014-08-20 赛特克罗公司 治疗维生素d不足和缺乏、继发性甲状旁腺功能亢进症和维生素d-响应疾病的组合物及其相应的制药用途
US20100204123A1 (en) * 2009-02-12 2010-08-12 Mary Elizabeth Pecquet Goad Peripheral Administration of Proteins Including TGF-beta Superfamily Members for Treatment of Systemic Disorders and Disease
JP5819734B2 (ja) * 2009-02-12 2015-11-24 ストライカー コーポレイションＳｔｒｙｋｅｒ Ｃｏｒｐｏｒａｔｉｏｎ ＴＧＦ−βスーパーファミリーメンバー含有タンパク質の最小に侵襲性の全身送達のための組成物および方法
RU2595804C1 (ru) * 2015-04-23 2016-08-27 Федеральное государственное бюджетное образовательное учреждение высшего образования "Саратовский государственный технический университет имени Гагарина Ю.А." (СГТУ имени Гагарина Ю.А.) Состав для получения стоматологической лечебно-профилактической пленки

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833125A (en) * 1986-12-05 1989-05-23 The General Hospital Corporation Method of increasing bone mass

Also Published As

Publication number Publication date
JPH06508140A (ja) 1994-09-14
BR9206110A (pt) 1995-07-11
CA2110410A1 (en) 1992-12-10
WO1992021365A1 (en) 1992-12-10
RU2107512C1 (ru) 1998-03-27
NO934381D0 (no) 1993-12-02
CZ262493A3 (en) 1994-07-13
SK136693A3 (en) 1994-10-05
PT100567A (pt) 1994-01-31
NZ243018A (en) 1995-12-21
IE921812A1 (en) 1992-12-16
EP0587751A1 (en) 1994-03-23
CZ282231B6 (cs) 1997-06-11
AU667815B2 (en) 1996-04-18
AU2145492A (en) 1993-01-08
CA2110410C (en) 1997-04-15

Similar Documents

Publication Publication Date Title
NO934381L (no) Terapeutiske sammensetninger for osteoinduksjon
ES2033434T3 (es) Composicion cosmetica.
DK337888A (da) Desodoriserende og antimikrobiel sammensaetning til anvendelse i kosmetiske eller topiske praeparater
IT8819961A0 (it) Dispositivo protesico composito modulare di gamba e piede.
SE8504967D0 (sv) A pharmaceutical composition and a method of treating the body
ES2149776T3 (es) Modulacion, inducida por un morfogeno, de la respuesta inflamatoria.
RU93058532A (ru) Фармацевтическая композиция для остеоиндукции, способ генерации новой кости
GR1002802B (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεως του δερματος
NL193399B (nl) Injecteerbare implantsamenstelling voor gebruik bij reconstructieve chirurgische behandelingen.
DE69316013D1 (de) Verwendung von phosphinate zur behandlung der osteoporose
MX9301387A (es) Metodo y composicion para el tratamiento de osteoporosis.
FI961336A0 (fi) Menetelmä silmänesteiden säilömiseksi ja koostumuksia tätä varten
SE8802869D0 (sv) Combination of pyramidine derivatives and retonoids, as separate components, for inducing and stimulating hair growth and reducing its loss
HUT66153A (en) Pharmaceutical compositions which can be used for preventing and treating of chemotherapy-induced alopecia
ATE250860T1 (de) Erhöhte stabilität von azadirachtin enthaltenden festen zubereitungen
SE8700156D0 (sv) Kosmetiska kompositioner med hudlugnande och hudgenerande effekt och forfarande for framstellning derav
ES2052670T3 (es) Utilizacion de derivados de 2-pirimidinil-1-piperazina.
SE8403659D0 (sv) Synergistic pharmaceutical composition
GR3024648T3 (en) Pharmaceutical preparation
ES2089387T3 (es) Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica.
MX9206135A (es) Metodos
DE3368199D1 (en) Mixture comprising a central analgesic and vitamin b12, or one of its analogs, as active principles
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
EP0521080A4 (en) Synergistic compositions
DK0572549T3 (da) Behandling af ikke-småcellet lungecarcinom